Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats
Revista Portuguesa de Cardiologia · 2025
DOI: 10.1016/j.repc.2024.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Portuguesa de Cardiologia, 2025. Verfasst von Shraddha I Khairnar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotonic Agents, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION AND OBJECTIVES: The current study evaluates the effect of chelidonic acid on doxorubicin-induced cardiac toxicity. Chelidonic acid (CA) is a natural pyran-skeleton heterocyclic compound found in rhizomes of the perennial plant, celandine (Chelidonium majus). METHODS: Wistar rats were given an intraperitoneal injection of doxorubicin (1.25 mg/kg, cumulative dose of 20 mg/kg) four times per week for a duration of four weeks to induce cardiotoxicity. CA treatment (10, 20, and 40 mg/kg orally for four weeks) was started together with doxorubicin. RESULTS: CA treatment reduced myocardial damage and improved cardiac dysfunction in doxorubicin-treated rats. It improved blood pressure, restored ST wave height and normalized the QTc interval compared to the rats treated only with doxorubicin. Administration of CA for four weeks reduced left ventricular end-diastolic pressure. Moreover, CA treatment decreased the level of cardiac markers such as creatine kinase-myocardial band (CK-MB), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and cardiac troponin-T. Masson's trichrome, hematoxylin, and eosin staining of heart tissue revealed that CA attenuated the deleterious effects of doxorubicin and prevented further damage and fibrosis in rats. CONCLUSION: The study findings confirm that CA treatment can protect the myocardium against doxorubicin-induced cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India.
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India. Electronic address: kspharma05@gmail.com.
Zitieren
APA
Khairnar, S. I., Kulkarni, Y. A., & Singh, K. (2025). Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats. Revista Portuguesa de Cardiologia. https://doi.org/10.1016/j.repc.2024.06.003
Vancouver
Khairnar SI, Kulkarni YA, Singh K. Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats. Revista Portuguesa de Cardiologia. 2025. doi:10.1016/j.repc.2024.06.003
BibTeX
@article{Khairnar2025,
author = {Khairnar, Shraddha I and Kulkarni, Yogesh A and Singh, Kavita},
title = {Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats},
journal = {Revista Portuguesa de Cardiologia},
year = {2025},
doi = {10.1016/j.repc.2024.06.003}
}
EUVIMED